metformin vs glp 1 TrimRX GLP-1 drugs beat metformin for
Description
Their approved indications in the UK remain type 2 diabetes management and weight management in adults with obesity, though anti-inflammatory effects may contribute to their broader cardiovascular and metabolic benefits
It may be appropriate for individuals with weight-loss resistance, insulin resistance, metabolic syndrome, PCOS, elevated cardiometabolic risk, or those who were unable to tolerate full-dose GLP-1 therapy
R.BoseS.WangJ
23 In clinical trials, treatment-discontinuation rates are around 5% to 10%
Idris, I., Abdulla, H., Tilbrook, S., Dean, R
Roche leverages its biologics manufacturing depth and diagnostics-driven care models to support patient monitoring and personalized treatment pathways
